06/10/2026
The 2026 AHA/ACC/ADA/ASN Cardiovascular-Kidney-Metabolic (CKM) Syndrome Guideline-at-a-Glance highlights CKM syndrome staging, PREVENT cardiovascular (CV) risk assessment, obesity and metabolic management strategies, kidney-protective therapies, and interdisciplinary approaches for reducing long-term CV and kidney risk.
Get started with implementing key recommendations into everyday clinical practice: https://bit.ly/4emLZrA